News & Analysis on Clinical Trial Services & Contract Research And Development
Denmark's Novozymes has set up a dedicated business unit in the UK to make and sell ingredients that support companies wanting to produce biopharmaceuticals without using animal-derived constituents.
UK firm Futura Medical is in the running for a second license contract for one of its drug delivery platforms after pharma heavyweight GlaxoSmithKline came to the table to discuss terms.
Varian has launched a new dissolution system specifically geared to testing small drug volumes in medical devices such as implants or drug-eluting stents.
Contract research organisation (CRO) Chiltern has announced it is expanding its services with a new solution aimed at helping clients boost their clinical research staff recruitment process - an increasingly difficult task due to the growing number of...
A new method for generating large volumes of therapeutic antibodies direct from Escherichia coli bacterium could knock weeks off conventional mass-production processes that scale up to mammalian cells, US researchers believe.
The ever increasing sales of high-voltage field emission Transmission Electron Microscopes (TEMs) highlights the growing importance of understanding structure-activity relationships in structural biology.
Successful applications of cold-form film and security foil helped the Pharma/Healthcare division of Austria's Constantia Packaging to deliver above-average growth in 2006, the company reported.
Biotech giant Amgen has posted healthy results for the first quarter following a positive performance by its blockbuster anaemia drug Aranesp (darbepoetin alfa).
Indian firm Biocon has recorded a healthy performance in the fiscal year 2007, as revenues in its research services unit soared.